Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.
Tzaridis T, Gepfner-Tuma I, Hirsch S, Skardelly M, Bender B, Paulsen F, Schaub C, Weller J, Schäfer N, Herrlinger U, Tabatabai G. Tzaridis T, et al. Neuro Oncol. 2019 Jul 11;21(7):954-955. doi: 10.1093/neuonc/noz071. Neuro Oncol. 2019. PMID: 31089718 Free PMC article. No abstract available.
Corticosteroid-responsive aseptic meningitis during regorafenib treatment.
Gepfner-Tuma I, Hirsch S, Schittenhelm J, Tzaridis T, Ziemann U, Tatagiba M, Herrlinger U, Tabatabai G. Gepfner-Tuma I, et al. Neurooncol Pract. 2019 Dec;6(6):508-509. doi: 10.1093/nop/npz030. Epub 2019 Jul 18. Neurooncol Pract. 2019. PMID: 32257278 Free PMC article. No abstract available.
Depatux-M and temozolomide in advanced high-grade glioma.
Hirsch S, Roggia C, Biskup S, Bender B, Gepfner-Tuma I, Eckert F, Zips D, Malek NP, Wilhelm H, Renovanz M, Tabatabai G. Hirsch S, et al. Among authors: gepfner tuma i. Neurooncol Adv. 2020 Jun 6;2(1):vdaa063. doi: 10.1093/noajnl/vdaa063. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32705082 Free PMC article. No abstract available.
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.
Behling F, Fodi C, Gepfner-Tuma I, Kaltenbach K, Renovanz M, Paulsen F, Skardelly M, Honegger J, Tatagiba M; International Consortium on Meningiomas; Schittenhelm J, Tabatabai G. Behling F, et al. Among authors: gepfner tuma i. Neuro Oncol. 2021 Aug 2;23(8):1273-1281. doi: 10.1093/neuonc/noaa303. Neuro Oncol. 2021. PMID: 33367841 Free PMC article.
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A; International Consortium on Meningiomas; Zadeh G, Aldape KD. Nassiri F, et al. Neuro Oncol. 2019 Jul 11;21(7):901-910. doi: 10.1093/neuonc/noz061. Neuro Oncol. 2019. PMID: 31158293 Free PMC article.
Integrative assessment of brain and bone invasion in meningioma patients.
Zwirner K, Paulsen F, Schittenhelm J, Gepfner-Tuma I, Tabatabai G, Behling F, Skardelly M, Bender B, Zips D, Eckert F. Zwirner K, et al. Among authors: gepfner tuma i. Radiat Oncol. 2019 Jul 29;14(1):132. doi: 10.1186/s13014-019-1341-x. Radiat Oncol. 2019. PMID: 31358024 Free PMC article. Clinical Trial.
Papillary tumor of the pineal region: a single-center experience.
Boßelmann CM, Gepfner-Tuma I, Schittenhelm J, Brendle C, Honegger J, Tabatabai G. Boßelmann CM, et al. Among authors: gepfner tuma i. Neurooncol Pract. 2020 Jul;7(4):384-390. doi: 10.1093/nop/npaa014. Epub 2020 Apr 3. Neurooncol Pract. 2020. PMID: 33133629 Free PMC article.
18 results